Anish Bhatnagar's Form 4 filing
Soleno Therapeutics Inc (SLNO) · filed Oct 3, 2024
- Accession no.
- 0001415889-24-024658
- Filed
- Oct 3, 2024
- Trade date
- Oct 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.07M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anish BhatnagarCIK 0001614821 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | SSaleDisposed | −19,413 | $49.34 | −$957,837.42 | 721,773 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −2,220 | $50.25 | −$111,555 | 719,553 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.